Natriuretic Peptides in Cardiovascular and Metabolic Crosstalk: Implications for Hypertension Management

Angiotensin-neprilysin inhibition versus enalapril in heart failure

McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957 · see citing works

Impact of Obesity on Plasma Natriuretic Peptide Levels

Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Wilson, P. W. F., & Vasan, R. S. (2004) · Circulation · doi:10.1161/01.cir.0000112582.16683.ea · Cited by 1,022 · see citing works

Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes

Bordicchia, M., Liu, D., Amri, E.-Z., Ailhaud, G., Dessì-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R., & Collins, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59701 · Cited by 872 · see citing works

Alterations of skeletal muscle in chronic heart failure.

Drexler, H., Riede, U. N., Münzel, T. F., König, H., Funke, E., & Just, H. (1992) · Circulation · doi:10.1161/01.cir.85.5.1751 · Cited by 780 · see citing works

The Failing Heart Relies on Ketone Bodies as a Fuel

Aubert, G., Martin, O. J., Horton, J. L., Lai, L., Vega, R. B., Leone, T. C., Koves, T. R., Gardell, S. J., Krüger, M., Hoppel, C. L., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017355 · Cited by 701 · see citing works

Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure.

Sullivan, M. J., Green, H. J., & Cobb, F. R. (1990) · Circulation · doi:10.1161/01.cir.81.2.518 · Cited by 689 · see citing works

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

Ruilope, L. M., Dukát, A., Böhm, M., Lacourcière, Y., Gong, J., & Lefkowitz, M. P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61966-8 · Cited by 598 · see citing works

Obesity and suppressed B-type natriuretic peptide levels in heart failure

Mehra, M. R., Uber, P. A., Park, M. H., Scott, R. L., Ventura, H. O., Harris, B. C., & Frohlich, E. D. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.066 · Cited by 534 · see citing works

Natriuretic peptides: a new lipolytic pathway in human adipocytes

Sengenès, C., Berlan, M., de Glisezinski, I., Lafontan, M., & Galitzky, J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1345 · Cited by 531 · see citing works

Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure

Newton‐Cheh, C., Larson, M. G., Vasan, R. S., Levy, D. A., Bloch, K. D., Surti, A., Guiducci, C., Kathiresan, S., Benjamin, E. J., Struck, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.328 · Cited by 395 · see citing works

Molecular Physiology of Membrane Guanylyl Cyclase Receptors

Kühn, M. (2016) · Physiological Reviews · doi:10.1152/physrev.00022.2015 · Cited by 358 · see citing works

Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial

Seferović, J. P., Claggett, B. L., Seidelmann, S. B., Seely, E. W., Packer, M., Zile, M. R., Rouleau, J. L., Swedberg, K. B., Lefkowitz, M. P., Shi, V. C., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30087-6 · Cited by 354 · see citing works

Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.

(2022) · Cineca Institutional Research Information System (Tor Vergata University) · doi:10.1161/circulationaha · Cited by 291 · see citing works

Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity

Miyashita, K., Itoh, H., Tsujimoto, H., Tamura, N., Fukunaga, Y., Sone, M., Yamahara, K., Taura, D., Inuzuka, M., Sonoyama, T., et al. (2009) · Diabetes · doi:10.2337/db09-0393 · Cited by 288 · cited 2× · see citing works

Involvement of a cGMP-dependent Pathway in the Natriuretic Peptide-mediated Hormone-sensitive Lipase Phosphorylation in Human Adipocytes

Sengenès, C., Bouloumié, A., Hauner, H., Berlan, M., Busse, R., Lafontan, M., & Galitzky, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303713200 · Cited by 267 · see citing works

Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice

Ayala, J. E., Bracy, D. P., Julien, B. M., Rottman, J. N., Fueger, P. T., & Wasserman, D. H. (2007) · Diabetes · doi:10.2337/db06-0883 · Cited by 237 · see citing works

Association of Plasma Natriuretic Peptide Levels With Metabolic Risk Factors in Ambulatory Individuals

Wang, T. J., Larson, M. G., Keyes, M. J., Levy, D. A., Benjamin, E. J., & Vasan, R. S. (2007) · Circulation · doi:10.1161/circulationaha.106.655142 · Cited by 206 · see citing works

Natriuretic peptides enhance the oxidative capacity of human skeletal muscle

Engeli, S., Birkenfeld, A. L., Badin, P.-M., Bourlier, V., Louche, K., Viguerie, N., Thalamas, C., Montastier, É., Larrouy, D., Harant, I., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64526 · Cited by 197 · see citing works

Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients

Dessı̀-Fulgheri, P., Sarzani, R., Tamburrini, P., Moraca, A., Espinosa, E., Cola, G., Giantomassi, L., & RAPPELLI, A. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715120-00074 · Cited by 195 · see citing works

In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats.

Yamamoto, K., Chappell, M. C., Brosnihan, K. B., & Ferrario, C. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.6.692 · Cited by 188 · see citing works

Atrial natriuretic peptide contributes to the physiological control of lipid mobilization in humans

Moro, C., Crampes, F., Sengenès, C., de Glisezinski, I., Galitzky, J., Thalamas, C., Lafontan, M., & Berlan, M. (2004) · The FASEB Journal · doi:10.1096/fj.03-1086fje · Cited by 176 · see citing works

Lipid Mobilization with Physiological Atrial Natriuretic Peptide Concentrations in Humans

Birkenfeld, A. L., Boschmann, M., Moro, C., Adams, F., Heusser, K., Franke, G., Berlan, M., Luft, F. C., Lafontan, M., & Jordan, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1953 · Cited by 165 · see citing works

Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity

Sengenès, C., Zakaroff‐Girard, A., Moulin, A., Berlan, M., Bouloumié, A., Lafontan, M., & Galitzky, J. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00453.2001 · Cited by 153 · see citing works

Low Plasma Level of Atrial Natriuretic Peptide Predicts Development of Diabetes: The Prospective Malmö Diet and Cancer Study

Magnusson, M., Jujić, A., Hedblad, B., Engström, G., Persson, M., Struck, J., Morgenthaler, N. G., Nilsson, P. M., Newton‐Cheh, C., Wang, T. J., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2425 · Cited by 149 · see citing works

Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome

Schlueter, N., de Sterke, A., Willmes, D. M., Spranger, J., Jordan, J., & Birkenfeld, A. L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.04.007 · Cited by 148 · see citing works

Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans

Birkenfeld, A. L., Budziarek, P., Boschmann, M., Moro, C., Adams, F., Franke, G., Berlan, M., Marqués, M.-A., Sweep, F. C. G. J., Luft, F. C., et al. (2008) · Diabetes · doi:10.2337/db08-0649 · Cited by 146 · see citing works

Atrial natriuretic peptide is negatively regulated by microRNA-425

Arora, P. K., Wu, C., Khan, A. M., Bloch, D. B., Davis‐Dusenbery, B. N., Ghorbani, A., Spagnolli, E., Martinez, A., Ryan, A., Tainsh, L. T., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67383 · Cited by 127 · see citing works

Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension

Jordan, J., Stinkens, R., Jax, T. W., Engeli, S., Blaak, E. E., May, M., Havekes, B., Schindler, C., Albrecht, D., Pal, P., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.455 · Cited by 123 · see citing works

Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-induced obesity and insulin resistance

Wu, W., Shi, F., Liu, D., Ceddia, R. P., Gaffin, R. D., Wei, W., Fang, H., Lewandowski, E. D., & Collins, S. (2017) · Science Signaling · doi:10.1126/scisignal.aam6870 · Cited by 118 · see citing works

NH2-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes

Lazo, M., Young, J. H., Brancati, F. L., Coresh, J., Whelton, S. P., Ndumele, C. E., Hoogeveen, R. C., Ballantyne, C. M., & Selvin, E. (2013) · Diabetes · doi:10.2337/db13-0478 · Cited by 107 · see citing works

Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure

Vodovar, N., Seronde, M., Laribi, S., Gayat, É., Lassus, J. P. E., Boukef, R., Nouira, S., Manivet, P., Samuel, J., Logeart, D., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu314 · Cited by 107 · see citing works

Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue

Hoffmann, L. S., Etzrodt, J., Willkomm, L., Sanyal, A., Scheja, L., Fischer, A. W., Stasch, J., Bloch, W., Friebe, A., Heeren, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8235 · Cited by 102 · see citing works

The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men

Galitzky, J., Sengenès, C., Thalamas, C., Marqués, M.-A., Sénard, J., Lafontan, M., & Berlan, M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31162-7 · Cited by 101 · see citing works

Atrial Natriuretic Peptide and Adiponectin Interactions in Man

Birkenfeld, A. L., Boschmann, M., Engeli, S., Moro, C., Arafat, A. M., Luft, F. C., & Jordan, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043238 · Cited by 90 · see citing works

Functional and Pharmacological Characterization of the Natriuretic Peptide-Dependent Lipolytic Pathway in Human Fat Cells

Moro, C., Galitzky, J., Sengenès, C., Crampes, F., Lafontan, M., & Berlan, M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060913 · Cited by 90 · see citing works

Defective Natriuretic Peptide Receptor Signaling in Skeletal Muscle Links Obesity to Type 2 Diabetes

Coué, M., Badin, P.-M., Vila, I. K., Laurens, C., Louche, K., Marqués, M.-A., Bourlier, V., Mouisel, É., Tavernier, G., Rustan, A. C., et al. (2015) · Diabetes · doi:10.2337/db15-0305 · Cited by 87 · see citing works

Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes

Kovacova, Z., Tharp, W. G., Liu, D., Wei, W., Xie, H., Collins, S., & Pratley, R. E. (2016) · Obesity · doi:10.1002/oby.21418 · Cited by 85 · see citing works

Treatment with Sildenafil Improves Insulin Sensitivity in Prediabetes: A Randomized, Controlled Trial

Ramirez, C. E., Nian, H., Yu, C., Gamboa, J. L., Luther, J. M., Brown, N. J., & Shibao, C. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3415 · Cited by 76 · see citing works

Cardiac natriuretic peptides promote adipose ‘browning’ through mTOR complex-1

Liu, D., Ceddia, R. P., & Collins, S. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2017.12.017 · Cited by 76 · see citing works

Racial Differences in Circulating Natriuretic Peptide Levels: The Atherosclerosis Risk in Communities Study

Gupta, D. K., Claggett, B. L., Wells, Q. S., Cheng, S. C., Li, M., Maruthur, N. M., Selvin, E., Coresh, J., Konety, S., Butler, K. R., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001831 · Cited by 73 · see citing works

Low Calorie Diet Enhances Renal, Hemodynamic, and Humoral Effects of Exogenous Atrial Natriuretic Peptide in Obese Hypertensives

Dessı̀-Fulgheri, P., Sarzani, R., Serenelli, M., Tamburrini, P., Spagnolo, D., Giantomassi, L., Espinosa, E., & RAPPELLI, A. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.658 · Cited by 71 · see citing works

Treatment with brain natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db/db mice

Plante, É., Ménaouar, A., Danalache, B. A., Broderick, T. L., Jankowski, M., & Gutkowska, J. (2014) · Diabetologia · doi:10.1007/s00125-014-3201-4 · Cited by 71 · see citing works

B-Type Natriuretic Peptide Modulates Ghrelin, Hunger, and Satiety in Healthy Men

Vila, G., Grimm, G., Resl, M., Heinisch, B. B., Einwallner, E., Esterbauer, H., Dieplinger, B., Mueller, T., Luger, A., & Clodi, M. (2012) · Diabetes · doi:10.2337/db11-1466 · Cited by 66 · see citing works

Insulin Signalling and Resistance in Patients with Chronic Heart Failure

Kemppainen, J., Tsuchida, H., Stolen, K. Q., Karlsson, H., Björnholm, M., Heinonen, O. J., Nuutila, P., Krook, A., Knuuti, J. M., & Zierath, J. R. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.042648 · Cited by 65 · see citing works

B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival

Holditch, S. J., Schreiber, C. A., Nini, R., Tonne, J. M., Peng, K.-W., Geurts, A. M., Jacob, H. J., Burnett, J. C. J., Cataliotti, A., & Ikeda, Y. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05610 · Cited by 65 · see citing works

Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise

Moro, C., Polak, J., Hejnová, J., Klimčáková, E., Crampes, F., Štich, V., Lafontan, M., & Berlan, M. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00348.2005 · Cited by 64 · see citing works

Impaired atrial natriuretic peptide-mediated lipolysis in obesity

Rydén, M., Bäckdahl, J., Petrus, P., Thorell, A., Gao, H., Coué, M., Langin, D., Moro, C., & Arner, P. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.222 · Cited by 61 · see citing works

Innovative Therapeutics

Meems, L. M. G., & Burnett, J. C. J. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.10.001 · Cited by 58 · see citing works

β-Adrenergic and Atrial Natriuretic Peptide Interactions on Human Cardiovascular and Metabolic Regulation

Birkenfeld, A. L., Boschmann, M., Moro, C., Adams, F., Heusser, K., Tank, J., Diedrich, A., Schroeder, C., Franke, G., Berlan, M., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1084 · Cited by 53 · see citing works

Natriuretic peptides promote glucose uptake in a cGMP-dependent manner in human adipocytes

Coué, M., Barquissau, V., Morigny, P., Louche, K., Lefort, C., Mairal, A., Carpéné, C., Viguerie, N., Arner, P., Langin, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19619-0 · Cited by 53 · see citing works

Atrial Natriuretic Peptide and Type 2 Diabetes Development – Biomarker and Genotype Association Study

Jujić, A., Nilsson, P. M., Engström, G., Hedblad, B., Melander, O., & Magnusson, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089201 · Cited by 52 · see citing works

Phosphodiesterase‐5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide‐mediated lipolysis

Moro, C., Klimčáková, E., Lafontan, M., Berlan, M., & Galitzky, J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707485 · Cited by 49 · see citing works

Effects of exercise on natriuretic peptides and cardiac function in man

Barletta, G., Stefani, L., Bene, R. D., Fronzaroli, C., Vecchiarino, S., Lazzeri, C., Fantini, F., & Villa, G. L. (1998) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00129-6 · Cited by 46 · see citing works

Differential response of the natriuretic peptide system to weight loss and exercise in overweight or obese patients

Haufe, S., Kaminski, J., Utz, W., Haas, V., Mähler, A., Daniels, M. A., Birkenfeld, A. L., Lichtinghagen, R., Luft, F. C., Schulz-Menger, J., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000573 · Cited by 41 · see citing works

Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension

Engeli, S., Stinkens, R., Heise, T., May, M., Goossens, G. H., Blaak, E. E., Havekes, B., Jax, T. W., Albrecht, D., Pal, P., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10224 · Cited by 41 · see citing works

Basal and Exercise-Induced Neuroendocrine Activation in Patients with Heart Failure and in Normal Subjects

Kjær, A., Appel, J. M., Hildebrandt, P. R., & Petersen, C. L. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00035-7 · Cited by 40 · see citing works

Metabolic Actions Could Confound Advantageous Effects of Combined Angiotensin II Receptor and Neprilysin Inhibition

Birkenfeld, A. L., Adams, F., Schroeder, C., Engeli, S., & Jordan, J. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.165159 · Cited by 35 · see citing works

Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPK

Souza, S. C., Chau, M. D. L., Yang, Q., Gauthier, M.-S., Clairmont, K. B., Wu, Z., Gromada, J., & Dole, W. P. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.143 · Cited by 34 · see citing works

Effects of sildenafil treatment on thermogenesis and glucose homeostasis in diet-induced obese mice

Johann, K., Reis, M. C., Harder, L., Herrmann, B., Gachkar, S., Mittag, J., & Oelkrug, R. (2018) · Nutrition and Diabetes · doi:10.1038/s41387-018-0026-0 · Cited by 34 · see citing works

Gastric Bypass Surgery Elevates NT-ProBNP Levels

Abrahamsson, N., Engström, B. E., Sundbom, M., & Karlsson, F. A. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0889-z · Cited by 33 · see citing works

Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study

Brutsaert, E. F., Biggs, M. L., Delaney, J. A., Djoussé, L., Gottdiener, J. S., Ix, J. H., Kim, F., Mukamal, K. J., Siscovick, D. S., Tracy, R. P., et al. (2016) · Metabolism · doi:10.1016/j.metabol.2016.06.002 · Cited by 32 · see citing works

A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA)

Cannone, V., Scott, C. G., Decker, P. A., Larson, N. B., Palmas, W., Taylor, K. D., Wang, T. J., Gupta, D. K., Bielinski, S. J., & Burnett, J. C. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189858 · Cited by 32 · see citing works

Sustained Blood Pressure–Lowering Actions of Subcutaneous B-Type Natriuretic Peptide (Nesiritide) in a Patient With Uncontrolled Hypertension

Cataliotti, A., Costello‐Boerrigter, L. C., Chen, H. H., Textor, S. C., & Burnett, J. C. J. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.02.003 · Cited by 29 · see citing works

The association between daily physical activity and plasma B-type natriuretic peptide in patients with glucose intolerance: a cross-sectional study

Hamasaki, H., Yanai, H., Kakei, M., Noda, M., & Ezaki, O. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006276 · Cited by 28 · see citing works

Neurohumoral and Metabolic Response to Exercise in Water

Wiesner, S., Birkenfeld, A. L., Engeli, S., Haufe, S., Brechtel, L. M., Wein, J., Hermsdorf, M., Karnahl, B., Berlan, M., Lafontan, M., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1248250 · Cited by 26 · see citing works

Attenuated atrial natriuretic peptide-mediated lipolysis in subcutaneous adipocytes of obese type 2 diabetic men

Verboven, K., Hansen, D., Moro, C., Eijnde, B. O., Hoebers, N., Knol, J., Bouckaert, W., Dams, A., Blaak, E. E., & Jocken, J. W. E. (2016) · Clinical Science · doi:10.1042/cs20160220 · Cited by 26 · see citing works

Atrial Natriuretic Peptide in the High Normal Range Is Associated With Lower Prevalence of Insulin Resistance

Jujić, A., Nilsson, P. M., Persson, M., Holst, J. J., Torekov, S. S., Lyssenko, V., Groop, L., Melander, O., & Magnusson, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3518 · Cited by 24 · see citing works

Short term variation in NTproBNP after lifestyle intervention in severe obesity

Fedele, D., Bicchiega, V., Collo, A., Barutta, F., Pistone, E., Gruden, G., & Bruno, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181212 · Cited by 24 · see citing works

ANP system activity predicts variability of fat mass reduction and insulin sensitivity during weight loss

Brachs, M., Wiegand, S., Leupelt, V., Ernert, A., Kintscher, U., von Schwartzenberg, R. J., Decker, A.-M., Bobbert, T., Hübner, N., Chen, W., et al. (2016) · Metabolism · doi:10.1016/j.metabol.2016.03.013 · Cited by 22 · see citing works

Plasma MR-proANP levels are associated with carotid intima-media thickness in the general community: The KORA F4 study

Then, C., Kowall, B., Lechner, A., Meisinger, C., Heier, M., Köenig, W., Peters, A., Thiery, J., Rathmann, W., & Seißler, J. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.047 · Cited by 20 · see citing works

The effect of surgical and non-surgical weight loss on N-terminal pro-B-type natriuretic peptide and its relation to obstructive sleep apnea and pulmonary function

Gabrielsen, A.-M., Omland, T., Brokner, M., Fredheim, J. M., Jordan, J., Lehmann, S., Lund, M. B., Hjelmesaeth, J. S., & Hofsø, D. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2241-x · Cited by 15 · see citing works

Role of supraspinal vasopressin neurones in the effects of atrial natriuretic peptide on sympathetic nerve activity

Yusof, A. P. M., Yusoff, N. H. M., Suhaimi, F. W., & Coote, J. H. (2009) · Autonomic Neuroscience · doi:10.1016/j.autneu.2009.03.005 · Cited by 13 · see citing works

The effects of angiotensin receptor neprilysin inhibition by sacubitril/valsartan on adipose tissue transcriptome and protein expression in obese hypertensive patients

Stinkens, R., van der Kolk, B. W., Jordan, J., Jax, T. W., Engeli, S., Heise, T., Jocken, J. W. E., May, M., Schindler, C., Havekes, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22194-z · Cited by 12 · see citing works

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans

Zois, N. E., Terzic, D., Færch, K., Plomgaard, P., Hansen, J. S., Rossing, P. R., & Goetze, J. P. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.02.026 · Cited by 11 · see citing works

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)

Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473 · see citing works

Obesity, kidney dysfunction and hypertension: mechanistic links

Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654 · see citing works

Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited

da Silva, A. A., do Carmo, J. M., Li, X., Wang, Z., Mouton, A. J., & Hall, J. E. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.066 · Cited by 381 · see citing works

Obesity, kidney dysfunction, and inflammation: interactions in hypertension

Hall, J. E., Mouton, A. J., da Silva, A. A., Omoto, A. C. M., Wang, Z., Li, X., & do Carmo, J. M. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa336 · Cited by 280 · see citing works

Sex-Related Differences in Contemporary Biomarkers for Heart Failure: A Review

Suthahar, N., Meems, L. M. G., Ho, J. E., & de Boer, R. A. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1771 · Cited by 99 · see citing works

Cardiovascular Pleiotropic Effects of Natriuretic Peptides

Forte, M., Madonna, M., Schiavon, S., Valenti, V., Versaci, F., Biondi‐Zoccai, G., Frati, G., & Sciarretta, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163874 · Cited by 87 · see citing works

Role of Cardiac Natriuretic Peptides in Heart Structure and Function

Sarzani, R., Allevi, M., Pentima, C. D., Schiavi, P., Spannella, F., & Giulietti, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214415 · Cited by 91 · see citing works

Confirming the bidirectional nature of the association between severe hypoglycemic and cardiovascular events in type 2 diabetes: insights from EXSCEL

Standl, E., Stevens, S. R., Lokhnygina, Y., Bethel, M. A., Buse, J. B., Gustavson, S. M., Maggioni, A. P., Mentz, R. J., Hernandez, A. F., & Holman, R. R. (2020) · Diabetes Care · doi:10.2337/dc19-1079 · Cited by 65 · see citing works

Diabetes Mellitus and Heart Failure

Triposkiadis, F. K., Xanthopoulos, A. V., Bargiota, Α., Kitai, T., Katsiki, N., Farmakis, D. T., Skoularigis, J. S., Starling, R. C., & Iliodromitis, E. K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163682 · Cited by 70 · see citing works

The Importance of Natriuretic Peptides in Cardiometabolic Diseases

Vinnakota, S., & Chen, H. H. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa052 · Cited by 54 · see citing works

Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis

Pandey, K. N. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.693099 · Cited by 56 · see citing works

Obesity: The Perfect Storm for Heart Failure

Lembo, M., Strisciuglio, T., Fonderico, C., Mancusi, C., Izzo, R., Trimarco, V., Bellis, A., Barbato, E., Esposito, G., Morisco, C., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14641 · Cited by 46 · see citing works

Epicardial adipose tissue thickness is associated with reduced peak oxygen consumption and systolic reserve in patients with type 2 diabetes and normal heart function

Nesti, L., Pugliese, N. R., Chiriacò, M., Tricò, D., Baldi, S., & Natali, A. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14861 · Cited by 42 · see citing works

Transfer of a Human Gene Variant Associated with Exceptional Longevity Improves Cardiac Function in Obese Type 2 Diabetic Mice Through Induction of the SDF-1/CXCR4 Signalling Pathway

Dang, Z., Avolio, E., Thomas, A. C., Faulkner, A., Beltrami, A. P., Cervellin, C., Carrizzo, A., Maciag, A. E., Gu, Y., Ciaglia, E., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1840 · Cited by 38 · see citing works

Obesity-and lipid-related indices as a risk factor of hypertension in mid-aged and elderly Chinese: a cross-sectional study

Gui, J., Li, Y., Liu, H., Guo, L., Li, J., Lei, Y., Li, X., Sun, L., Yang, L., Yuan, T., et al. (2024) · BMC Geriatrics · doi:10.1186/s12877-023-04650-2 · Cited by 33 · see citing works

Association between a metabolic score for insulin resistance and hypertension: results from National Health and Nutrition Examination Survey 2007–2016 analyses

Zeng, J., Zhang, T., Yang, Y. C., Wang, J., Zheng, D., Hou, Y., Tong, Y., Fan, X., Wang, X., & Fang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1369600 · Cited by 30 · see citing works

Subclinical Cardiovascular Disease in US Adults With and Without Diabetes

Fang, M., Wang, D., Tang, O., McEvoy, J. W., Echouffo-Tcheugui, J. B., Christenson, R. H., & Selvin, E. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029083 · Cited by 30 · see citing works

Beneficial Effects of the Ketogenic Diet in Metabolic Syndrome: A Systematic Review

Charlot, A., & Zoll, J. (2022) · Diabetology · doi:10.3390/diabetology3020020 · Cited by 28 · see citing works

Simultaneous inhibition of neprilysin and activation of ACE2 prevented diabetic cardiomyopathy

Malek, V., Sharma, N., & Gaikwad, A. B. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.05.008 · Cited by 22 · see citing works

Corin: A Key Mediator in Sodium Homeostasis, Vascular Remodeling, and Heart Failure

Zhang, X., Gu, X., Zhang, Y., Dong, N., & Wu, Q. (2022) · Biology · doi:10.3390/biology11050717 · Cited by 22 · see citing works

Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-Analysis

Spannella, F., Giulietti, F., Bordicchia, M., Burnett, J. C. J., & Sarzani, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-55680-z · Cited by 22 · see citing works

Renal Natriuretic Peptide Receptor-C Deficiency Attenuates NaCl Cotransporter Activity in Angiotensin II–Induced Hypertension

Shao, S., Li, X., Lu, Y., Li, S., Chen, X.-H., Zhou, H., He, S., Guo, Y., Lu, X., Gao, P., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.15636 · Cited by 21 · see citing works

Natriuretic Peptides and Risk of Type 2 Diabetes: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium

Sujana, C., Salomaa, V. V., Kee, F., Costanzo, S., Söderberg, S., Jordan, J., Jousilahti, P., Neville, C. E., Iacoviello, L., Oskarsson, V., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0811 · Cited by 19 · see citing works

Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study

Sujana, C., Seißler, J., Jordan, J., Rathmann, W., Köenig, W., Roden, M., Mansmann, U., Herder, C., Peters, A., Thorand, B., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01117-1 · Cited by 18 · see citing works

Possible Association Between Body Temperature and B-Type Natriuretic Peptide in Patients With Cardiovascular Diseases

Kang, R., Nagoshi, T., Kimura, H., Tanaka, T. D., Yoshii, A., Inoue, Y., Morimoto, S., Ogawa, K., Minai, K., Ogawa, T., et al. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.08.012 · Cited by 18 · see citing works

Complexity analysis from EEG data in congestive heart failure: A study via approximate entropy

Cacciotti, A., Pappalettera, C., Miraglia, F., Valeriani, L., Judica, E., Rossini, P. M., & Vecchio, F. (2023) · Acta Physiologica · doi:10.1111/apha.13979 · Cited by 17 · see citing works

MANP in Hypertension With Metabolic Syndrome

Ma, X., McKie, P. M., Iyer, S. R., Scott, C., Bailey, K. R., Johnson, B. K., Benike, S. L., Chen, H. H., Miller, W. L., Cabassi, A., et al. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.08.011 · Cited by 12 · see citing works

Exogenous ANP Treatment Ameliorates Myocardial Insulin Resistance and Protects against Ischemia–Reperfusion Injury in Diet-Induced Obesity

Oi, Y., Nagoshi, T., Kimura, H., Tanaka, Y., Yoshii, A., Yasutake, R., Takahashi, H., Kashiwagi, Y., Tanaka, T. D., Tachibana, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158373 · Cited by 12 · see citing works

Collaborative Activities of Noradrenaline and Natriuretic Peptide for Glucose Utilization in Patients with Acute Coronary Syndrome

Uno, G., Nagoshi, T., Yoshii, A., Inoue, Y., Tanaka, Y., Kimura, H., Ito, S., Ogawa, K., Tanaka, T. D., Minai, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44216-0 · Cited by 12 · see citing works

Activation of GLP-1 receptor signalling by sacubitril/valsartan: Implications for patients with poor glycaemic control

Mahtani, K., Patel, B., Wang, B. Z., & Barron, A. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.08.015 · Cited by 12 · see citing works

Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Ostrominski, J. W., Neuen, B. L., Claggett, B. L., Anand, I. S., Desai, A. S., Jhund, P. S., Lam, C. S. P., Pfeffer, M. A., Pitt, B., Zannad, F. M., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.028 · Cited by 9 · see citing works

Cardiac morphological and functional changes induced by C-type natriuretic peptide are different in normotensive and spontaneously hypertensive rats

Caniffi, C., Santos, E. P., Cerniello, F. M., Tomat, A. L., Maglio, D. H. G., Toblli, J. E., & Arranz, C. T. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002570 · Cited by 9 · see citing works

Role of natriuretic peptides in the cardiovascular-adipose communication: a tale of two organs

Mikusic, N. L. R., Kouyoumdzian, N. M., Puyó, A. M., Fernández, B. E., & Choi, M. R. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02596-1 · Cited by 10 · see citing works

Cross talk on therapeutic strategies: natriuretic peptides and inhibiting neprilysin in hypertension management

Jangid, M. K., & Doshi, G. (2024) · Hypertension Research · doi:10.1038/s41440-024-01989-w · Cited by 8 · see citing works

Heart failure risk estimation based on novel biomarkers

Ataklte, F., & Vasan, R. S. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1933446 · Cited by 7 · see citing works

Plasma proatrial natriuretic peptide associates with lipid oxidation during exercise and cardiorespiratory fitness in healthy young adults

Thomsen, C. F., Ried‐Larsen, M., Goetze, J. P., Andersen, L. B., Faber, J. O., Grøntved, A., & Jeppesen, J. (2019) · Peptides · doi:10.1016/j.peptides.2019.170156 · Cited by 7 · see citing works

Atrial natriuretic peptide signaling co-regulates lipid metabolism and ventricular conduction system gene expression in the embryonic heart

Mishra, A. K., Tavasoli, M., Sokolenko, S., McMaster, C. R., & Pasumarthi, K. B. S. (2023) · iScience · doi:10.1016/j.isci.2023.108748 · Cited by 6 · see citing works

Cardiac‐Focused Multi‐Organ Chips: Advanced Disease Modeling, Drug Testing, and Inter‐Organ Communication

Zhang, X., Wang, Y., Han, J., Zhao, W., Zhang, W., Li, X., Chen, J., Song, W., & Wang, L. (2025) · Advanced Biology · doi:10.1002/adbi.202400512 · Cited by 5 · see citing works

The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator

Thirumathyam, R., Richter, E. A., van Hall, G., Holst, J. J., Fenger, M., Goetze, J. P., Dixen, U., Vejlstrup, N. G., Madsbad, S., Madsen, P. L., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02094-x · Cited by 5 · see citing works

Intensive Lifestyle Intervention Increases Plasma Midregional Proatrial Natriuretic Peptide Concentrations in Overweight Children

Thomsen, C. F., Goharian, T. S., Larsen, K. T., Goetze, J. P., Andersen, L. B., & Jeppesen, J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.020676 · Cited by 4 · see citing works

Role of brain natriuretic peptide in the pathogenesis of resistant hypertension

Nikolaev, К. Y., Shilova, A. V., Kovaleva, A. Y., & Израйлевна, Л. Г. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5188 · Cited by 4 · see citing works

Atrial natriuretic peptide and leptin interactions in healthy men

Daniels, M. A., Fischer‐Posovszky, P., Boschmann, M., von Schwartzenberg, R. J., Müller, T. D., Sandforth, L., Frank, S., Hülskämper, S., Peter, A., Wabitsch, M., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1195677 · Cited by 4 · see citing works

The Africans in America study demonstrates that subclinical cardiovascular risk differs by etiology of abnormal glucose tolerance

Wentzel, A., Karera, M. G. D., Patterson, A. C., Waldman, Z. C., Schenk, B. R., Mabundo, L. S., DuBose, C. W., Horlyck-Romanovsky, M., & Sumner, A. E. (2022) · Scientific Reports · doi:10.1038/s41598-022-19917-8 · Cited by 3 · see citing works

Obesity and Hypertension: Pathophysiology and Treatment

Hall, M. E., Omoto, A. C. M., do Carmo, J. M., da Silva, A. A., & Hall, J. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00037-2 · Cited by 3 · see citing works

Pathophysiology and Optimal Management of Hypertension in Patients with Cardiometabolic Syndrome

Ihm, S. (2021) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2021.1.e3 · Cited by 3 · see citing works

Computational Investigation of Smooth Muscle Cell Plasticity in Atherosclerosis and Vascular Calcification: Insights from Differential Gene Expression Analysis of Microarray Data

Liu, D., Kuo, J., & Lin, C.-H. (2025) · Bioengineering · doi:10.3390/bioengineering12111223 · Cited by 2 · see citing works

Natriuretic Peptides as Multisystem Regulators: From Clinical Biomarkers to Therapeutic Targets in Cardio-immunology

PANNEFLEK, J., Barbarawi, M., KAKARLAPUDI, Y., Barbarawi, Z., Lauzea, B., & Meraz-Torres, M. (2025) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-025-07821-y · Cited by 2 · see citing works

Atrial Natriuretic Peptide

Huang, K., Zhang, L., & Zhang, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_1064 · Cited by 2 · see citing works

CLINICAL SIGNIFICANCE OF NATRIURETIC PEPTIDES (review)

Zhuravlyova, L., Сокольнікова, Н., & Rogachova, T. (2022) · Inter Collegas · doi:10.35339/ic.9.1.5-13 · Cited by 1 · see citing works

SALVE: prediction of interorgan communication with transcriptome latent space representation

Pavelka, J., Voong, C. K., Schaal, P., Lam, M. P. Y., & Lau, E. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00637.2025 · Cited by 1 · see citing works

Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy

Standl, E., Ceriello, A., McGuire, D. K., Schnell, O., & Holman, R. R. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02959-3 · Cited by 1 · see citing works

Non-HDL-C/HDL-C Ratio and N-Terminal Pro-B-Type Natriuretic Peptide in the general and hospital-based population: a cross-sectional validation study

Xie, H., Li, J., Shen, L., Yu, P., Wang, S., Xiaohu, C. H. E. N., & Shuhua, T. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1739961 · Cited by 1 · see citing works

Treating obesity and heart failure: a how-to-manage guide from the European Association for the Study of Obesity and the European Society of Hypertension working group on diabetes and metabolic risk factors

Antza, C., Jordan, J., McGowan, B. M., Ciudin, A., Filippi-Arriaga, F., Hönemann, J., Jelacovic, A., Nilsson, P. M., Tsioufis, K. P., Doehner, W., et al. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004285 · Cited by 1 · see citing works

Cardiac Natriuretic Peptide System: A Link between Adipose Tissue, Obesity, and Insulin Resistance

Öztop, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104560 · Cited by 1 · see citing works

Fasudil, a Rho kinase inhibitor, attenuates cardiovascular changes in an experimental rat model of metabolic syndrome via modulation of PCSK9 and BNP.

Shamardl, H. A., Nageeb, S., Sadik, S., Helal, A., & Shabana, M. (2024) · Fayoum University Medical Journal/Fayoum University Medical Journal · doi:10.21608/fumj.2024.259818.1309 · Cited by 1 · see citing works

NT-proANP levels in peripheral and cardiac circulation

Buttner, P. G., Seewöster, T., Obradović, D., Hindricks, G., Thiele, H., & Kornej, J. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-021-01020-z · Cited by 1 · see citing works

Celebrating 40 Years of Accomplishments

Dominiczak, A. F., Kuo, D., Bhalla, V., Granger, J. P., & Griffin, K. A. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.12252

Atrial Natriuretic Peptide

Huang, K., Zhang, L., & Zhang, C. (2020) · Springer eBooks · doi:10.1007/978-3-319-69892-2_1064-1

Serum B-type natriuretic peptide does not increase with higher systolic blood pressure in obese men despite evidence of blood pressure-related increases in left ventricular mass and filling pressure

Asferg, C. L., Andersen, U. B., Linneberg, A. R., Hedley, P. L., Christiansen, M., Goetze, J. P., & Jeppesen, J. (2020) · Peptides · doi:10.1016/j.peptides.2020.170390

Precision Medicine for Diabetes and Cardiovascular Disease

Wan, S., & Chen, H. H. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_2

The landscape of N 6-methyladenosine modification patterns and altered transcript profiles in the cardiac-specific deletion of natriuretic peptide receptor A

Xi Zhong, S. H. E. N., Chang, P., Zhang, X., Zhang, J., Wang, X., Quan, Z., Wang, P., Liu, T., Niu, Y., Zheng, R., et al. (2022) · Molecular Omics · doi:10.1039/d2mo00201a

Adipositas-assoziierte Hypertonie

Engeli, S. (2023) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/a-2059-9094

ASSOCIATION BETWEEN BRAIN NATRIURETIC PEPTIDE LEVELS AND MARKERS OF THE SEVERITY OF RESISTANT ARTERIAL HYPERTENSION

Panarina, A. Y., Nikolaev, К. Y., Shilova, A. V., & Израйлевна, Л. Г. (2024) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2024-13-3s-27-36

Effects of Atrial Natriuretic Peptide on Interorgan Crosstalk

Rosa, G. M., Costa, P., & Ad, V. G. (2025) · Springer eBooks · doi:10.1007/978-3-032-01024-7_25

Additional file 1 of Obesity-and lipid-related indices as a risk factor of hypertension in mid-aged and elderly Chinese: a cross-sectional study

Gui, J., Li, Y., Liu, H., Guo, L.-L., Li, J., Lei, Y., Li, X., Sun, L., Yang, L., Yuan, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25036236

Additional file 1 of Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study

Sujana, C., Seissler, J., Jordan, J., Rathmann, W., Koenig, W., Roden, M., Mansmann, U., Herder, C., Peters, A., Thorand, B., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13106513

Additional file 1 of The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator

Thirumathyam, R., Richter, E. A., van Hall, G., Holst, J. J., Fenger, M., Gøtze, J. P., Dixen, U., Vejlstrup, N., Madsbad, S., Madsen, P. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26664142

Natriuretic peptide signaling as a therapeutic target in POTS: physiological opportunities and caveats

Jordan, J., Pesta, D. H., & Moro, C. (2026) · Clinical Autonomic Research · doi:10.1007/s10286-026-01194-4

Natriuretic Peptides in Cardiovascular and Metabolic Crosstalk: Implications for Hypertension Management

Jordan, J., Birkenfeld, A. L., Melander, O., & Moro, C. (2018) · Kölner Universitäts PublikationsServer (Universität zu Köln)

Natriuretic Peptides and Metabolic Hypertension

Goetze, J. P., & Rehfeld, J. F. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.11.007 · Cited by 1 · see citing works

[Hypertension and natriuretic peptide family].

Ito, H., & Nakao, K. (1995) · PubMed

Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events

Kerkelä, R., Ulvila, J., & Magga, J. M. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002423 · Cited by 172 · see citing works

Natriuretic Peptides

Richards, M. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.069153 · Cited by 48 · see citing works